MAHA: Health Secretary RFK Jr. announces new FDA move to fast-track biosimilar drug approvals. “The result will be more competition, lower prices and faster access to lifesaving medicines.”
InstaPundit is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.